Systemic Inflammation Decreases Pain Threshold in Humans In Vivo

Abstract

BackgroundHyperalgesia is a well recognized hallmark of disease. Pro-inflammatory cytokines have been suggested to be mainly responsible, but human data are scarce. Changes in pain threshold during systemic inflammation evoked by human endotoxemia, were evaluated with three quantitative sensory testing methods. Methods and ResultsPressure pain thresholds, electrical pain thresholds and tolerance to the cold pressor test were measured before and 2 hours after the intravenous administration of 2 ng/kg purified E. coli endotoxin in 27 healthy volunteers. Another 20 subjects not exposed to endotoxemia served as controls. Endotoxemia led to a rise in body temperature and inflammatory symptom scores and a rise in plasma TNF-α, IL-6, IL-10 and IL-1RA. During endotoxemia, pressure pain thresholds and electrical pain thresholds were reduced with 20±4 % and 13±3 %, respectively. In controls only a minor decrease in pressure pain thresholds (7±3 %) and no change in electrical pain thresholds occurred. Endotoxin-treated subjects experienced more pain during the cold pressor test, and fewer subjects were able to complete the cold pressor test measurement, while in controls the cold pressor test results were not altered. Peak levels and area under curves of each individual cytokine did not correlate to a change in pain threshold measured by one of the applied quantitative sensory testing techniques. Conclusions and SignificanceIn conclusion, this study shows that systemic inflammation elicited by the administration of endotoxin to humans, results in lowering of the pain threshold measured by 3 quantitative sensory testing techniques. The current work provides additional evidence that systemic inflammation is accompanied by changes in pain perception.

Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: Associations with painful symptoms

“…In models controlling for all other measures of inflammation, the relationships between TLR-4 inflammatory responses and pain scales were not attenuated; this provides strong evidence that TLR-4 mediated inflammation specifically plays a critical role in IC/BPS pain symptoms. These findings may be related to recent work demonstrating that experimental induced endotoxemia via LPS administration reduces pain thresholds in healthy subjects [8]. …”

The effect of sleep deprivation on pain perception in healthy subjects: a meta-analysis

“…A recent meta-analysis showed that sleep disturbance is associated with increase in markers of systemic inflammation [99]. Interestingly, systemic inflammation resulted in lowering pain threshold [100]. Additionally, the tumor necrosis factor (TNF) system [101] as well as the hypothalamic-pituitary-adrenal-axis [102] are influenced by sleep and pain.…”

Altered Central Sensitization and Pain Modulation in the CNS in Chronic Joint Pain

“…During systemic inflammation after administration of endotoxin to volunteers, widespread pressure hypersensitivity develops [102]. Furthermore, low-dose endotoxin potentiates capsaicin-induced pain and hyperalgesia/allodynia [103].…”